Research Must Go On
This is the final installment of my Memo series illustrating why research funding for basic and clinical trials should never stop unless the approach is obviously misdirected. Delaying research due to the dogma of the day is bad; delaying it because someone believes in a refuted dogma is worse. This is not a debate on whether vaccines can cause autism. The data is clear to me; autism is the direct or indirect result of genetic mutations, most of which have not been fully researched. But many people still have questions, so let’s say that someone were to direct research to examine vaccinations as a potential cause for autism, specifically the mumps, measles, and rubella (MMR) vaccine. How should it be done?
First, every child should have complete genetic testing that includes every suspected gene that’s been associated with autism—specifically, retrograde autism, the most serious form. The children should also have a complete microbiome examination because a weak immune system may be related to the development of autism. The genetics and microbiomes of both parents should also be tested.
Second, the children should be randomly selected throughout the United States covering all geographic areas.
Third, the parent should decide whether they choose to have their children vaccinated or not; the decision should not be influenced by healthcare professionals.
Fourth, the key time for retrograde autism is within two weeks of the vaccinations; the diagnosis process should begin within that time frame.
Finally, it has to be a blinded study. That means that neither the physicians nor the parents can be told of the purpose of the study other than to agree to monitor the development of the child.
There are hundreds of details and other variables that need to be worked out, but that’s the basic idea. We’ve had numerous studies that included over a million children that were retrospective observational studies, and that’s great information, but doing a study before children are vaccinated is the best way to answer whether vaccinations are related to autism. The side benefit is that we will have genetic and microbiome profiles to compare with those who were and were not vaccinated and those who were and were not diagnosed with retrograde autism. Anything less would not answer the question.
One more thing: The scientific board that controls the funding can have no part in selecting where and how the research is conducted.
If we did all that—and it’s absolutely doable if we have the will to do it—we could finally answer the questions about vaccines and autism. Since we’re talking about the lives of children, I think most of us would agree it’s a great use of research funds because we could finally know that vaccines are safe.
The Bottom Line
Research on health and disease has to continue without political influence. I’ve tried to illustrate the problems with research delayed by professional and personal dogma as well as an idea of the timeline of how long it takes to get answers. When you get right down to it, can we afford to delay even one second? The next solution might just impact you or someone you care about.
What are you prepared to do today?
Dr. Chet
References:
1. N Engl J Med. 2002 Nov 7;347(19):1477-82
2. Ann Intern Med. 2019 Apr 16;170(8):513-520